CYNAPSUS ANNOUNCES DEBENTURE FINANCING
TORONTO, ONTARIO--(Marketwire - Nov. 24, 2010) -
Cynapsus Therapeutics Inc. ("Cynapsus" or the "Corporation") (formerly Cannasat Therapeutics Inc.) (TSX VENTURE:CTH) announced today that it has secured financing (the "Financing") of a secured Series B debenture ("Secured Debenture") in the aggregate amount of $100,000. MORE>>
